AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO will present a Company update. AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) stock performance was -8.38% in last session and finished the day at $11.92. Traded volume was 1.46million shares in the last session and … Continue reading Healthcare Bearish Stocks: AcelRx Pharmaceuticals (NASDAQ:ACRX), BioCryst Pharmaceuticals (NASDAQ:BCRX), Baxano Surgical (NASDAQ:BAXS), Flamel Technologies (NASDAQ:FLML)